Early research suggests the potential anticancer therapeutics might be especially risky for patients with prior or ongoing heart disease. Medscape Medical News
The use of DES was associated with a 38% lower risk of all-cause mortality compared with bare-metal stents, a finding that was persistent despite multiple adjustments, including a propensity-matched and subgroup analysis, report investigators. Heartwire
Children who survive cancer are at risk for premature cardiovascular disease and should be closely monitored for their whole lives. Medscape Medical News
Hypothyroidism in women with rheumatoid arthritis was linked with a higher risk for cardiovascular disease vs women with a healthy thyroid and an already established increased cardiovascular risk. Medscape Medical News
A previously observed cut in hospitalization risk has been shown in a follow-up analysis to have come at a cost within the typically accepted range. Heartwire
Investigators report a definite stent thrombosis recurrence in nearly 20% of patients who had an initial event; nearly 15% of patients who had a first stent thrombosis died during follow-up. Heartwire
